NRI Doctor's R&D Model in India to Slash Cost of Drugs
A British doctor of Indian origin and his colleague are set to drastic...Sunil Shaunak professor of infectious diseases at Imperial Colleg...The two academics have devised a way to invent new medicines and g...The Guardian reported Tuesday that Shaunak called their revolution... The process has the potential to undermine the monopoly of the bi...
A British doctor of Indian origin and his colleague are set to drastically lower the cost of medicines //and pose a challenge to the monopoly of multinational drug companies.
Sunil Shaunak, professor of infectious diseases at Imperial College, London, and Steve Brocchini from the London School of Pharmacy are leading clinical trials in India for a drug for hepatitis C.
The two academics have devised a way to invent new medicines and get them to market at a fraction of the cost charged by big drug companies. Their model is likely to enable millions in poor countries to be cured of infectious diseases and reduce the drugs bill of Britain's National Health Service.
The Guardian reported Tuesday that Shaunak called their revolutionary new model "ethical pharmaceuticals". Improvements devised to the molecular structure of an existing, expensive drug turned it technically into a new medicine, which was no longer under a 20-year patent to a multinational drug company and could be made and sold cheaply.
"The process has the potential to undermine the monopoly of the big drug companies and bring cheaper drugs not only to poor countries but back to the UK," the newspaper reported.
It added that Shaunak and Brocchini had linked up with an unnamed Indian biotech company, which will manufacture the first drug - for hepatitis C - if clinical trials in India are successful. The report added that the trials are sponsored by the Indian government.
Hepatitis C reportedly affects 170 million people worldwide and at least 200,000 in Britain.
Multinational drug companies put the cost of the research and development of a new drug at $800 million. According to Shaunak and Brocchini, the cost of developing their drug will be only a few million pounds.
The report added that Imperial College would hold the patent on the hepatitis C drug to prevent anybody attempting to block its development. The '"/>
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... to impossible, but a new study adds to a ... CT scans may help spot the beginnings of disease ... the greatest risk for lung cancer, 6 percent were ... and follow-up biopsies to confirm the diagnosis. CT scans ...
(Date:5/21/2013)... Sunnyvale, California (PRWEB) May 21, 2013 ... invites individuals who are grieving to remember and honor ... an Evening of Remembrance Memorial Service, Sunday, June 2, ... at Skyline Boulevard, San Mateo, CA 94402. , ... non-denominational, and includes a short program with music, readings ...
(Date:5/21/2013)... Calif. (PRWEB) May 21, 2013 Not ... a dual diagnosis of Borderline Personality Disorder (BPD) and ... is proving to be successful for the treatment of ... 1, Alina Gorgorian, Ph.D., clinical director of Clearview ... in Los Angeles, will provide attendees of the West ...
(Date:5/21/2013)... more likely than their normal-weight counterparts to repeatedly ... continuity of care and leads to more emergency ... The practice of "doctor shopping" among overweight patients ... the health care system, whether that be off-putting ... by providers, or improperly sized medical equipment and ...
(Date:5/21/2013)... N.C. An attack on glioblastoma brain tumor cells ... in an early study to establish the proper dose ... treatment, developed at Duke and tested in an ongoing ... cells have an abundance of receptors that work like ... the cells. , The investigational therapy, known as ...
... makers debate what levels of ozone in the air are ... that the inhaled pollutant impairs the bodys first line of ... as bacteria. , While it has long been known ... pollution, is associated with increased cardiovascular and pulmonary hospitalizations and ...
... Programs in ... Need, BUDAPEST, Hungary, Sept. 29 With more ... each year, it has never,been more critical to increase ... the U.S.-Middle East Partnership for,Breast Cancer Awareness and Research, ...
... finds 123 deaths linked to the products since 1969 ... experts on Friday urged the federal Food and Drug ... and cold medicines for young children. , The recommendation, ... in children under 2, and antihistamines in those younger ...
... MCLEAN, Va., Sept. 28 Sunrise Senior Living,Inc. ... on the status of the independent,investigation being conducted ... Directors, provided an update on management,s Sarbanes-Oxley,Section 404 ... on legal,proceedings. Special Independent Committee Investigation ...
... a,statement by ADA President Kathleen Roth, DDS, on ... Bill: "The American Dental Association applauds the ... in legislation reauthorizing,the State Children,s Health Insurance Program. ... care that they need to enjoy good,oral health. ...
... Medical today announced a,partnership with leading breast care ... including breast care physicians from,Connecticut to California, will ... and availability of an innovative, non-surgical,treatment option for ... will host a gathering of these new Centers ...
(Date:5/21/2013)... May 21, 2013 Reportlinker.com announces ... available in its catalogue: ... for Optical Coherence Tomography (OCT) ... STUDY OBJECTIVES ... to offer synopsis of the current and ...
(Date:5/21/2013)... , May 21, 2013 Healthcare organizations expanding into ... Russia , India ... there are no shortcuts. This is proving particularly challenging, ... States. Companies must change the dialogue around BRIC, as ... local needs, and building regional partnerships to build a ...
(Date:5/21/2013)... 21, 2013 Reportlinker.com announces that ... in its catalogue: ... for Medical Devices in the US Market ... Changing Regulatory and Reimbursement Scenario ... Summary ...
... Aug. 24 With flu season fast approaching, PTCB ... role in immunization efforts at retail pharmacies across the ... 7.4 million patients against H1N1 and seasonal influenza with ... the 2010–2011 influenza season, Walgreens healthcare providers in pharmacies ...
... Inc. (Nasdaq: VRUS ) announced today that dosing has ... polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The ... with pegylated interferon alfa 2a and ribavirin, the current standard of ... been treated previously. "We look for the Phase ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...